BiotechCorp Annual Report 2007 - Malaysian Biotechnology ...

Facts & Figures
Malaysia’s competitive edge is its biodiversity
of natural resources and strong
industrial and manufacturing capabilities.
Coupled with strong economic
fundamentals, excellent infrastructure,
political stability and skilled workforce,
Malaysia has the potential and the
right environment for the biotechnology
industry to flourish. A National
Biotechnology Policy was formulated in
2005 by the Government that outlined
Malaysia’s niche and competitive advantages
in biotechnology.
Since the implementation of the policy,
various initiatives have been undertaken
by both the Government and
private sectors to enhance the growth
of the biotechnology industry, as well
as to strengthen the operational and
legal framework. Initiatives implemented
under the policy have generated results
which contributed to the escalation of the
biotechnology activities by international
and local participants.
Expected Global Biotechnology
Revenue Generation
Expected Growth
2006 - 2011
Expected Revenue
by 2011
12%
US271.4
billion
Asia Pacific Biotechnology Revenue
Revenue 2006
US36.7
billion
Global Biotechnology
Revenue by Sectors
Healthcare
62.5%
USD96.1bil
Others
26.0%
USD39.9bil
Agriculture
11.5%
USD17.7bil
The BioNexus Companies at a Glance
2007
No. of BioNexus Companies 42
Approved Investment (RM’billion) 1.08
Market Capitalisation (RM’million) 676.5
No. of Employees 1,040
Global Market
Capitalisation Growth
2006 USD153.7 billion 12.6%
Growth
2005 USD136.5 billion
Malaysian Market Capitalisation
Growth (2007)
2007 RM2.5 billion 0.3%
Growth
2006 RM2.1 billion
Number of Malaysian
Biotechnology Companies
Listed in 2007
Healthcare sector 7
Other sectors 4
Total companies 11
3